Paraneoplastic skin diseases

Paraneoplastic skin diseases (PSD) comprise a heterogeneous group of dermatoses associated with internal malignancies but are not caused by direct infiltration of the skin by tumor cells themselves. Instead, they reflect tumor-driven systemic effects mediated by hormones, growth factors, cytokines, antigens, or immune responses. A true paraneoplastic relationship is most likely when the dermatosis develops shortly before, concurrently with, or shortly after the diagnosis of the malignancy, and when both conditions follow a parallel clinical course. In this review, we revisit the concept of paraneoplastic dermatoses and propose a pragmatic classification into high-risk cutaneous paraneoplasias and low-to-moderate risk cutaneous paraneoplasias, rather than relying on the traditional distinction between “obligatory” and “facultative” entities. Particular emphasis is placed on high-risk disorders, including acrokeratosis paraneoplastica (Bazex syndrome), erythema gyratum repens, necrolytic migratory erythema, paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome, hypertrichosis lanuginosa acquisita, and selected acanthotic syndromes such as malignant acanthosis nigricans, tripe palms, and florid cutaneous papillomatosis. For each entity, we summarize the characteristic clinical presentation, common tumor associations, histopathologic clues, current concepts of pathogenesis, differential diagnoses, and therapeutic implications. We also briefly address selected low-to-moderate risk paraneoplastic dermatoses, including dermatomyositis as well as Sweet syndrome, pyoderma gangrenosum, and autoimmune bullous diseases. Recognition of PSD is of major clinical importance because cutaneous signs may precede the diagnosis of cancer and thus provide an opportunity for early detection of an otherwise occult malignancy. Close interdisciplinary collaboration among dermatologists, pathologists, oncologists, and other specialists is essential for accurate diagnosis, timely tumor work-up, and optimal patient management.

Authors

Institutions

Publication Details

Journal
SKINdeep
Published
2026-11-13
DOI
https://doi.org/10.1553/skindeep.2026.208593
Primary Topic
Skin Diseases and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Paraneoplastic skin diseases

Peter Wolf, Lorenzo Cerroni, Matthias Schmuth, Wolfgang Weninger et al.
1 links
SKINdeep
Skin Diseases and Diabetes
article

Paraneoplastic skin diseases

Peter Wolf, Lorenzo Cerroni, Matthias Schmuth, Wolfgang Weninger, Georg Stingl, Johann W. Bauer
article en

Abstract

Paraneoplastic skin diseases (PSD) comprise a heterogeneous group of dermatoses associated with internal malignancies but are not caused by direct infiltration of the skin by tumor cells themselves. Instead, they reflect tumor-driven systemic effects mediated by hormones, growth factors, cytokines, antigens, or immune responses. A true paraneoplastic relationship is most likely when the dermatosis develops shortly before, concurrently with, or shortly after the diagnosis of the malignancy, and when both conditions follow a parallel clinical course. In this review, we revisit the concept of paraneoplastic dermatoses and propose a pragmatic classification into high-risk cutaneous paraneoplasias and low-to-moderate risk cutaneous paraneoplasias, rather than relying on the traditional distinction between “obligatory” and “facultative” entities. Particular emphasis is placed on high-risk disorders, including acrokeratosis paraneoplastica (Bazex syndrome), erythema gyratum repens, necrolytic migratory erythema, paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome, hypertrichosis lanuginosa acquisita, and selected acanthotic syndromes such as malignant acanthosis nigricans, tripe palms, and florid cutaneous papillomatosis. For each entity, we summarize the characteristic clinical presentation, common tumor associations, histopathologic clues, current concepts of pathogenesis, differential diagnoses, and therapeutic implications. We also briefly address selected low-to-moderate risk paraneoplastic dermatoses, including dermatomyositis as well as Sweet syndrome, pyoderma gangrenosum, and autoimmune bullous diseases. Recognition of PSD is of major clinical importance because cutaneous signs may precede the diagnosis of cancer and thus provide an opportunity for early detection of an otherwise occult malignancy. Close interdisciplinary collaboration among dermatologists, pathologists, oncologists, and other specialists is essential for accurate diagnosis, timely tumor work-up, and optimal patient management.

SKINdeepVol. 2
Innsbruck Medical University (AT), Universität Innsbruck (AT), Medical University of Graz (AT), Paracelsus Medical University (AT), Medical University of Vienna (AT)
Good health and well-being
Skin Diseases and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon